Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018 Year: 2019
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007
Rationale for use of inhaled steroids in children with bronchiectasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019
Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001
Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities Source: Eur Respir Rev, 26 (145) 160123; 10.1183/16000617.0123-2016 Year: 2017
Comparative effectiveness of steroids and bronchodilators for the acute care of bronchiolitis Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014
Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012
Risks of pneumonia in asthmatic patients taking inhaled corticosteroids Source: Annual Congress 2010 - Management of airway disease Year: 2010
Economic outcomes in the United States of treating COPD with inhaled corticosteroids and long-acting β-agonists in a managed care setting Source: Eur Respir J 2003; 22: Suppl. 45, 216s Year: 2003
Long-term safety of inhaled formoterol in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002
Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012
Considerations about cost-effectiveness and global satisfaction of asthmatic patients treated with montelukast compared with inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
Comparative studies of inhaled corticosteroids in asthma Source: Eur Respir J 2001; 17: 579-580 Year: 2001
Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019 Year: 2020
Efficacy and safety of AZD3199, an inhaled ultra long-acting β2 -agonist, in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011